MedTrace Logo

Xerotic Dermatitis in Aged People

NCT01806935 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 442

Last updated 2013-09-26

No results posted yet for this study

Summary

The purpose of the study is to assess the the effect of the study product on itching symptoms associated with xerotic dermatitis in aged population

Conditions

  • Itching Symptoms
  • Xerotic Dermatitis

Interventions

DEVICE

DC086

DEVICE

Placebo

Sponsors & Collaborators

  • Pierre Fabre Medical Devices

    lead INDUSTRY

Principal Investigators

  • Yves Rolland · Hôpital Purpan CHU TOULOUSE, France

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01806935 on ClinicalTrials.gov